Position in MRK
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$31,414,523
+$1,733,207 QoQ
Shares Held
244,471
-0.9% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
4.24%
of 13F equity value
Holder Rank
#417
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WILKINS INVESTMENT COUNSEL INC holds $77,139,543 across 7 Drug Manufacturers - General names. MRK ranks #1 (40.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
This page
|
244,471 | $31,414,523 | |
| 2 | NVS |
Novartis AG
|
111,067 | $17,406,420 | |
| 3 | JNJ |
Johnson & Johnson
|
66,797 | $16,964,434 | |
| 4 | PFE |
Pfizer Inc
|
176,761 | $4,256,404 | |
| 5 | ABBV |
AbbVie Inc.
|
14,832 | $3,732,324 | |
| 6 | LLY |
ELI LILLY & Co
|
2,484 | $2,979,384 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,700 | $386,054 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,414,523 | 244,471 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $29,681,316 | 246,748 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $26,352,472 | 250,356 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $22,384,718 | 266,707 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $20,864,676 | 263,576 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $22,669,516 | 252,557 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $24,204,677 | 243,312 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $27,536,255 | 242,482 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $30,252,510 | 244,366 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $32,404,412 | 245,581 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $18,558,692 | 170,232 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $17,568,623 | 170,652 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $20,132,324 | 174,472 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $19,503,202 | 183,318 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $21,209,312 | 191,161 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $17,226,066 | 200,024 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $18,481,891 | 202,719 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $16,946,935 | 206,544 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $15,757,720 | 205,607 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $15,257,244 | 203,132 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $15,519,547 | 199,557 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $15,257,429 | 197,917 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $16,121,300 | 197,082 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $16,868,470 | 203,357 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $15,634,740 | 202,182 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $15,492,401 | 201,357 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||